Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biochemical modulation of 5-fluorouacil through dihydropyrimidine dehydrogenase inhibition: a Southwest Oncology Group phase II trial of eniluracil and 5-fluorouracil in advanced resistant colorectal cancer.
Leichman CG, Chansky K, Macdonald JS, Doukas MA, Budd GT, Giguere JK, Abbruzzese JL; Southwest Oncology Group. Leichman CG, et al. Among authors: macdonald js. Invest New Drugs. 2002 Nov;20(4):419-24. doi: 10.1023/a:1020662113061. Invest New Drugs. 2002. PMID: 12448660 Clinical Trial.
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.
Whitehead RP, Benedetti JK, Abbruzzese JL, Ardalan B, Goodwin JW, Balcerzak SP, Samlowski WE, Lenz HJ, Macdonald JS. Whitehead RP, et al. Among authors: macdonald js. Invest New Drugs. 2004 Aug;22(3):335-41. doi: 10.1023/B:DRUG.0000026261.76197.54. Invest New Drugs. 2004. PMID: 15122082 Clinical Trial.
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.
Whitehead RP, Benedetti JK, Abbruzzese JL, Ardalan B, Williamson S, Gaynor ER, Balcerzak SP, Macdonald JS. Whitehead RP, et al. Among authors: macdonald js. Invest New Drugs. 2004 Nov;22(4):467-73. doi: 10.1023/B:DRUG.0000036689.28596.c6. Invest New Drugs. 2004. PMID: 15292717 Clinical Trial.
353 results